Palindromic rheumatism as part of the rheumatoid arthritis continuum (original) (raw)
Guerne, P. A. & Weisman, M. H. Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am. J. Med.93, 451–460 (1992). ArticleCASPubMed Google Scholar
Hench, P. & Rosenberg, E. F. Palindromic rheumatism. A ‘new’ oft recurring disease of joints (arthritis, periarthritis, para-arthritis) apparently producing no articular residues. Report of thirty-four cases; its relation to angio-neural arthrosis’, ‘allergic rheumatism’ and rheumatoid arthritis. Arch. Int. Med.73, 293–321 (1944). Article Google Scholar
Mankia, K. & Emery, P. What can palindromic rheumatism tell us? Best Pract. Res. Clin. Rheumatol.31, 90–98 (2017). ArticlePubMed Google Scholar
Russell, A. S., Devani, A. & Maksymowych, W. P. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J. Rheumatol.33, 1240–1242 (2006). CASPubMed Google Scholar
Tamai, M. et al. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. Scand J. Rheumatol.39, 287–291 (2010). ArticleCASPubMed Google Scholar
Ansell, B. M. & Bywaters, E. G. Palindromic rheumatism. Ann. Rheum. Dis.18, 330 (1959). Article Google Scholar
Koskinen, E., Hannonen, P. & Sokka, T. Palindromic rheumatism: longterm outcomes of 60 patients diagnosed in 1967-84. J. Rheumatol.36, 1873–1875 (2009). ArticlePubMed Google Scholar
Gonzalez-Lopez, L. et al. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J. Rheumatol.26, 540–545 (1999). CASPubMed Google Scholar
Wajed, M. A., Brown, D. L. & Currey, H. L. Palindromic rheumatism. Clinical and serum complement study. Ann. Rheum. Dis.36, 56–61 (1977). ArticleCASPubMedPubMed Central Google Scholar
Hannonen, P., Mottonen, T. & Oka, M. Palindromic rheumatism. A clinical survey of sixty patients. Scand. J. Rheumatol.16, 413–420 (1987). ArticleCASPubMed Google Scholar
Salvador, G. et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology42, 972–975 (2003). CAS Google Scholar
Emad, Y. et al. In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up. Clin. Rheumatol.33, 791–797 (2014). ArticlePubMed Google Scholar
Khabbazi, A. et al. A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Int. J. Rheum. Dis.15, 427–430 (2012). ArticlePubMed Google Scholar
Mankia K., et al. Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Ann. Rheum. Dis. 2018.
Chen, H. H. et al. Association of ultrasonographic findings of synovitis with anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with palindromic rheumatism during active episodes. J. Ultrasound Med.28, 1193–1199 (2009). ArticlePubMed Google Scholar
Fisher, L. R. et al. HLA antigens in palindromic rheumatism and palindromic onset rheumatoid arthritis. Br. J. Rheumatol.25, 345–348 (1986). ArticleCASPubMed Google Scholar
Gran, J. T., Husby, G. & Thorsby, E. HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis. J. Rheumatol.11, 136–140 (1984). CASPubMed Google Scholar
Barbieri, P., Ciompi, M. L., Menicucci, A. & Pasero, G. HLA antigens in palindromic rheumatism. An Italian study. Clin. Rheumatol.7, 470–473 (1988). CASPubMed Google Scholar
Bregeon, C. et al. [Palindromic rheumatism. Immunological survey and study of development in 43 cases]. Rev. Rhum. Mal. Osteoartic.53, 441–449 (1986). CASPubMed Google Scholar
Maksymowych, W. P. et al. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. J. Rheumatol.29, 2319–2326 (2002). CASPubMed Google Scholar
Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum.30, 1205–1213 (1987). ArticleCASPubMed Google Scholar
Navalho, M. et al. Bilateral evaluation of the hand and wrist in untreated early inflammatory arthritis: a comparative study of ultrasonography and magnetic resonance imaging. J. Rheumatol.40, 1282–1292 (2013). ArticlePubMed Google Scholar
Cañete, J. D. et al. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum.56, 2784–2788 (2007). ArticleCASPubMed Google Scholar
Cañete, J. D. et al. Association of intermittent hydrarthrosis with MEFV gene mutations. Arthritis Rheum.54, 2334–2335 (2006). ArticleCASPubMed Google Scholar
Kim, S. K., Lee, H. S., Lee, K. W., Bae, S. C. & Jun, J. B. Palindromic rheumatism: different genetic background implies a distinct disease entity. Ann. Rheum. Dis.65, 1539–1540 (2006). ArticlePubMedPubMed Central Google Scholar
Chen, H. C. D. et al. Predicting the progression of palindromic rheumatism to rheumatoid arthritis: the role of ultrasonography and anti-cyclic citrullinated peptide antibodies. J. Med. Ultrasound18 17–26 (2010). Article Google Scholar
Bugatti, S. et al. Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis. Ann. Rheum. Dis.71, 625–626 (2012). ArticlePubMed Google Scholar
Cabrera-Villalba, S. et al. Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonographic study according to anticitrullinated protein antibody status. J. Rheumatol.41, 1650–1655 (2014). ArticlePubMed Google Scholar
Mankia K., D’Agostino M. A., Emery P. Response to: ‘Ultrasound findings in palindromic rheumatism’ by Sanmarti et al. Ann. Rheum. Dis.https://doi.org/10.1136/annrheumdis-2018-214867 (2018).
Youssef, W., Yan, A. & Russell, A. S. Palindromic rheumatism: a response to chloroquine. J. Rheumatol.18, 35–37 (1991). CASPubMed Google Scholar
Gonzalez-Lopez, L., Gamez-Nava, J. I., Jhangri, G., Russell, A. S. & Suarez-Almazor, M. E. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J. Rheumatol.27, 41–46 (2000). CASPubMed Google Scholar
Rempenault C. et al. Clinical and structural efficacy of hydroxychloroquine in rheumatoid arthritis: a systematic review. Arthritis Care Res.https://doi.org/10.1002/acr.23826 (2019).
Rothschild, B. & Yakubov, L. E. Evidence for an effect of hydroxychloroquine in chronic pyrophosphate deposition disease. J. Clin. Rheumatol.2, 170 (1996). ArticleCASPubMed Google Scholar
Schwartzberg, M. Prophylactic colchicine therapy in palindromic rheumatism. J. Rheumatol.9, 341–343 (1982). CASPubMed Google Scholar
Zemer, D., Livneh, A., Danon, Y. L., Pras, M. & Sohar, E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum.34, 973–977 (1991). ArticleCASPubMed Google Scholar
Ozen, S. et al. EULAR recommendations for the management of familial Mediterranean fever. Ann. Rheum. Dis.75, 644–651 (2016). ArticleCASPubMed Google Scholar
Savic, S. et al. Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases. RMD Open3, e000550 (2017). ArticlePubMedPubMed Central Google Scholar
van Echteld I., Wechalekar M. D., Schlesinger N., Buchbinder R., Aletaha D. Colchicine for acute gout. Cochrane Database Syst. Rev.8, CD006190 (2014).
Andres, M. & Pascual, E. Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation. Ann. Rheum. Dis.72, 155 (2013). ArticlePubMed Google Scholar
van der Hilst, J., Moutschen, M., Messiaen, P. E., Lauwerys, B. R. & Vanderschueren, S. Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature. Biologics10, 75–80 (2016). PubMedPubMed Central Google Scholar
Ben-Zvi, I. et al. Anakinra for colchicine-resistant familial mediterranean fever: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol.69, 854–862 (2017). ArticleCASPubMed Google Scholar
Harrison, S. R. et al. Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology. JCI Insight1, e86336 (2016). ArticlePubMedPubMed Central Google Scholar
Naumann, L. et al. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still’s disease. Ann. Rheum. Dis.69, 466–467 (2010). ArticleCASPubMed Google Scholar
Tran, A. P. & Edelman, J. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout. Int. J. Rheum. Dis.14, e33–e37 (2011). ArticlePubMed Google Scholar
Gerlag, D. M. et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann. Rheum. Dis.71, 638–641 (2012). ArticlePubMed Google Scholar
Mankia, K. & Emery, P. Preclinical rheumatoid arthritis: progress toward prevention. Arthritis Rheumatol.68, 779–788 (2016). ArticlePubMed Google Scholar
Stack, R. J. et al. Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development. Rheumatology53, 1646–1653 (2014). ArticleCASPubMed Google Scholar
Nam, J. L., Hunt, L., Hensor, E. M. & Emery, P. Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms — a cohort study. Ann. Rheu. Dis.75, 1452–1456 (2016). Article Google Scholar
Bos, W. H. et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann. Rheum. Dis.69, 490–494 (2010). ArticleCASPubMed Google Scholar
van Steenbergen, H. W. & van der Helm-van Mil, A. H. Clinical expertise and its accuracy in differentiating arthralgia patients at risk for rheumatoid arthritis from other patients presenting with joint symptoms. Rheumatology55, 1140–1141 (2016). ArticlePubMed Google Scholar
van Steenbergen, H. W., Mangnus, L., Reijnierse, M., Huizinga, T. W. & van der Helm-van Mil, A. H. Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis. Ann. Rheum. Dis.75, 1824–1830 (2016). ArticlePubMed Google Scholar
Hunt, L. et al. OP0042 In ACPA positive at-risk individuals, which MRI and US findings best predict development of clinical synovitis? Ann. Rheum. Dis.77 (Suppl 2), 72–73 (2018). Google Scholar
Kleyer, A. et al. High prevalence of tenosynovial inflammation before onset of rheumatoid arthritis and its link to progression to RA-A combined MRI/CT study. Semin. Arthritis Rheum.46, 143–150 (2016). ArticleCASPubMed Google Scholar
Mankia, K. et al. MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis. Ann. Rheum. Dis.78, 781–786 (2019). ArticlePubMed Google Scholar
Schett, G. & Firestein, G. S. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann. Rheum. Dis.69, 787–789 (2010). ArticlePubMed Google Scholar
Duer, A., Ostergaard, M., Horslev-Petersen, K. & Vallo, J. Magnetic resonance imaging and bone scintigraphy in the differential diagnosis of unclassified arthritis. Ann. Rheum. Dis.67, 48–51 (2008). ArticleCASPubMed Google Scholar
Kleyer, A. et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann. Rheum. Dis.73, 854–860 (2014). ArticlePubMed Google Scholar
Nam, J. L. et al. Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis. Ann. Rheum. Dis.75, 2060–2067 (2016). ArticlePubMed Google Scholar
Freeston, J. E. et al. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann. Rheum. Dis.69, 417–419 (2010). ArticleCASPubMed Google Scholar
Mosor E. et al. I would never take preventive medication! Perspectives and information needs of people who underwent predictive tests for rheumatoid arthritis. Arthritis Care Res.https://doi.org/10.1002/acr.23841 (2019).
So, A., De Smedt, T., Revaz, S. & Tschopp, J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther.9, R28 (2007). ArticlePubMedPubMed CentralCAS Google Scholar
Zufferey, P. et al. Efficacy of anakinra in acute hydroxyapatite calcification-induced joint pain: a retrospective study of 23 cases. Joint Bone Spine86, 83–88 (2019). ArticleCASPubMed Google Scholar
Schlesinger, N. et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann. Rheum. Dis.70, 1264–1271 (2011). ArticleCASPubMed Google Scholar
Schlesinger, N. et al. Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann. Rheum Dis.71, 1839–1848 (2012). ArticleCASPubMed Google Scholar
Clark, W., Jobanputra, P., Barton, P. & Burls, A. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. Health Technol. Assess.8, 1–105, iii-iv, ix-x (2004). Article Google Scholar
Scott, I. C. et al. A randomised trial evaluating anakinra in early active rheumatoid arthritis. Clin. Exp. Rheumatol.34, 88–93 (2016). PubMed Google Scholar
Pasero, G. & Barbieri, P. Palindromic rheumatism: you just have to think about it! Clin. Exp. Rheumatol.4, 197–199 (1986). CASPubMed Google Scholar
Sanmarti, R. et al. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study. J. Rheumatol.39, 1929–1933 (2012). ArticlePubMed Google Scholar